Preserving Well-being in Patients With Advanced and Late Prostate Cancer

Urology. 2021 Sep:155:199-209. doi: 10.1016/j.urology.2020.12.018. Epub 2020 Dec 26.

Abstract

Androgen deprivation therapy, alone or in combination with androgen signaling inhibitors, is a treatment option for patients with advanced prostate cancer (PC). When making treatment decisions, health care providers must consider the long-term effects of treatment on the patient's overall health and well-being. Herein, we review the effects of these treatments on the musculoskeletal and cardiovascular systems, cognition, and fall risk, and provide management approaches for each. We also include an algorithm to help health care providers implement best clinical practices and interdisciplinary care for preserving the overall well-being of PC patients.

Publication types

  • Review

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Androgen Antagonists / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Male
  • Neoplasm Staging
  • Practice Guidelines as Topic
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology

Substances

  • Androgen Antagonists
  • Antineoplastic Agents